The excretion of three gonadal steroids was studied in the urine and feces of female cotton-top tamarins (Saguinus oedipus oedipus). Each steroid, I4C-estrone, 14C-estradiol, and 14C-progesterone, was injected into a separate female cotton-top tamarin. Urine and feces were collected at 8 hr intervals for 5 days on the three tamarins. Samples were analyzed to determine the proportion of free and conjugated steroids. Steroid excretion patterns were determined by sequential ether extraction, enzyme hydrolysis, and chromatography. Labeled estrone was excreted in a slow and continuous manner into the urine (57%) and feces (43%) with 90% of the steroid conjugated. The nonconjugated form had an elution profile identical to 3H estrone, but the conjugated portion was not completely hydrolyzed by enzyme. Labeled estradiol was excreted primarily in the urine (87%) and was released rapidly. Over 90% of the injected 14C-estradiol was excreted in urine as a conjugate, of which 41% was converted to an estrone conjugate and the remaining 59% was excreted as a polar estradiol conjugate. Labeled progesterone was excreted primarily in the feces (95%), 61% of which was free steroid. Four to six individual peaks of radioactivity were found when using celite chromatography and high performance liquid chromatography (HPLC), indicating that progesterone is metabolized into several urinary and fecal metabolites. One of these peaks matched 3H-progesterone and others may be pregnanediols, pregnanetriols, and 17-hydroxyprogesterone. These steroidal excretion patterns help explain the atypical hormonal patterns seen during the tamarin ovarian cycle.
In this study, we sought to identify and characterize cytosolic androgen and estrogen receptors in the brain and anterior pituitary gland (AP) of fetal rhesus monkeys using the technique of DNA-cellulose chromatography. Cytosolic extracts were prepared from fetal monkey (days 135-162 of gestation) tissues including hypothalamus-preoptic area/amygdala (HPOA/AMG), cerebral cortex, and AP. Extracts were incubated with [3H]testosterone, [3H]5 alpha-dihydrotestosterone, or [3H] 17 beta-estradiol and applied to DNA-cellulose columns. [3H]Androgen- and [3H]estrogen-binding activities from cytosolic extracts adhered to DNA-cellulose. After elution with a linear salt gradient (10-500 mM NaCl) [3H]androgen-binding activity exhibited elution maxima between 130-150 mM NaCl, while [3H] estrogen-binding activity exhibited elution maxima between 200-220 mM NaCl. These elution patterns were similar in every region examined and were characteristic of putative androgen and estrogen receptors found in other vertebrate species. Additional experiments established the high affinity-low capacity nature of both androgen- and estrogen-binding activities, as well as their inhibition by known competitors of receptor binding. Estimates of binding activity at ligand concentrations that approximated saturation suggested that the concentration (moles specific bound per mg cytosolic protein) of both androgen and estrogen receptor were highest in the AP, intermediate in the HPOA/AMG, and lowest in the cerebral cortex. Comparisons of androgen- and estrogen-binding activities revealed that in the AP, apparent concentrations of the estrogen receptor exceeded those of androgen. Androgen and estrogen receptor concentrations were roughly equivalent in the HPOA/AMG, whereas, in the cerebral cortex, androgen receptor concentration was greater than estrogen. Collectively, these data demonstrate that in the fetal primate brain and AP, distinct androgen and estrogen receptors are present which might mediate the action of gonadal steroids on sexual differentiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.